Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up †
Article in Annals of Oncology (August 2023)
The most recent citing publications are shown below. View all 104 publications that cite this research output on Dimensions.
Anlotinib induces apoptosis and second growth/mitosis phase block in cisplatin-resistant ovarian cancer cells via the aurora kinase A/p53 pathway.
Article in Human & Experimental Toxicology (July 2023)
Clinical perspectives of rare ovarian tumors: clear cell ovarian cancer.
Article in Japanese Journal of Clinical Oncology (June 2023)